Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Structural considerations of autoantibodies.

M P Madaio1, Y Naparstek

  • 1Renal and Hypertension Division, University of Pennsylvania, Philadelphia, Pennsylvania, USA. madaio@mail.med.upenn.edu

Lupus
|January 17, 2003
PubMed
Summary

Peptide-induced immunosuppression in lupus-prone mice involves T cell recognition and altered cytokine profiles (IFN-g, IL-4, TGF-b). This suggests potential therapeutic strategies using anti-DNA antibodies for targeted cellular modification.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A liposomal steroid nano-drug for treating systemic lupus erythematosus.

Lupus·2016
Same author

Rituximab induces resolution of recurrent diffuse alveolar hemorrhage in a patient with primary antiphospholipid antibody syndrome.

Lupus·2011
Same author

Antibodies against the VRT101 laminin epitope correlate with human SLE disease activity and can be removed by extracorporeal immunoadsorption.

Rheumatology (Oxford, England)·2007
Same author

Outcome of a national Israeli cohort of pediatric systemic lupus erythematosus.

Lupus·2007
Same author

Simvastatin protection against acute immune-mediated glomerulonephritis in mice.

Kidney international·2006
Same author

Alveolar hemorrhage in cryoglobulinemia--an indicator of poor prognosis.

Clinical and experimental rheumatology·2005

Area of Science:

  • Immunology
  • Autoimmunity
  • Molecular Biology

Background:

  • Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by immune system dysregulation.
  • Understanding the mechanisms of immunosuppression in lupus-prone models is crucial for developing effective treatments.

Purpose of the Study:

  • To elucidate the mechanisms underlying peptide-induced immunosuppression in lupus-prone BWF1 mice.
  • To investigate the role of T cells and cytokine profiles in this process.
  • To explore the potential of anti-DNA antibody-mediated protein transport as a therapeutic modality.

Main Methods:

  • Induction of immunosuppression using specific peptides in lupus-prone BWF1 mice.
  • Analysis of T cell responses to peptides.
  • Quantification of serum cytokines, including Interferon-gamma (IFN-g), Interleukin-4 (IL-4), and Transforming Growth Factor-beta (TGF-b).
  • Investigation of anti-DNA antibody-mediated intracellular protein delivery.

Main Results:

  • Peptide-induced immunosuppression was mediated by T cell recognition, demonstrating peptide specificity.
  • Some peptides accelerated the autoimmune response.
  • Associated with decreased serum IFN-g and IL-4 levels.
  • Associated with increased serum TGF-b levels.
  • Isolation of peptide-specific T cells facilitated mechanistic studies.
  • Anti-DNA antibodies demonstrated the ability to transport linked proteins into cells.

Conclusions:

  • T cell recognition plays a key role in peptide-induced immunosuppression in lupus-prone mice.
  • Specific peptides can modulate autoimmune responses and cytokine profiles.
  • The anti-DNA antibody system offers a potential platform for targeted therapeutic interventions in autoimmune diseases by modifying cellular activities.

Related Experiment Videos